HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.670
+0.030 (1.14%)
At close: Dec 5, 2025, 4:00 PM EST
2.680
+0.010 (0.37%)
After-hours: Dec 5, 2025, 4:00 PM EST
HeartSciences Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Revenue | 0.01 | 0 | 0.02 | 0.01 | 0.01 | 0.03 | |
| Revenue Growth (YoY) | -66.40% | -76.61% | 261.17% | -64.17% | -43.86% | -60.11% | |
| Cost of Revenue | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 | |
| Gross Profit | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 | |
| Selling, General & Admin | 4 | 3.97 | 3.44 | 3.65 | 1.71 | 0.87 | |
| Research & Development | 4.16 | 4.39 | 2.88 | 2.46 | 3 | 1.71 | |
| Operating Expenses | 8.15 | 8.36 | 6.32 | 6.12 | 4.72 | 2.58 | |
| Operating Income | -8.15 | -8.35 | -6.31 | -6.11 | -4.71 | -2.57 | |
| Interest Expense | -0.66 | -0.5 | -0.35 | -0.24 | -0.37 | -0.13 | |
| Other Non Operating Income (Expenses) | 0.04 | 0.09 | 0.05 | 0 | 0 | -0 | |
| EBT Excluding Unusual Items | -8.77 | -8.77 | -6.61 | -6.35 | -5.08 | -2.7 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0 | |
| Other Unusual Items | - | - | - | - | 0.25 | 0.25 | |
| Pretax Income | -8.77 | -8.77 | -6.61 | -6.35 | -4.83 | -2.45 | |
| Net Income | -8.77 | -8.77 | -6.61 | -6.35 | -4.83 | -2.45 | |
| Net Income to Common | -8.77 | -8.77 | -6.61 | -6.35 | -4.83 | -2.45 | |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 105.27% | 166.16% | 343.39% | 139.56% | 0.15% | - | |
| EPS (Basic) | -8.20 | -9.34 | -18.74 | -79.92 | -145.48 | -74.00 | |
| EPS (Diluted) | -8.20 | -9.34 | -18.74 | -79.92 | -145.48 | -74.00 | |
| Free Cash Flow | -7.35 | -7.42 | -6.13 | -5.79 | -3.65 | -2.45 | |
| Free Cash Flow Per Share | -6.87 | -7.90 | -17.40 | -72.85 | -109.86 | -74.02 | |
| Gross Margin | 57.76% | 56.78% | 67.31% | 45.71% | 45.11% | 58.35% | |
| Operating Margin | -130416.37% | -192013.13% | -33901.99% | -118698.33% | -32765.60% | -10030.18% | |
| Profit Margin | -140296.54% | -201499.52% | -35511.87% | -123384.27% | -33592.57% | -9577.29% | |
| Free Cash Flow Margin | -117612.77% | -170486.23% | -32981.93% | -112463.79% | -25367.54% | -9580.56% | |
| EBITDA | -8.12 | -8.31 | -6.28 | -6.09 | -4.68 | -2.53 | |
| D&A For EBITDA | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| EBIT | -8.15 | -8.35 | -6.31 | -6.11 | -4.71 | -2.57 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.